BPG is committed to discovery and dissemination of knowledge
Featured Articles
4/25/2024 9:18:13 AM | Browse: 237 | Download: 363
 |
Received |
|
2024-01-25 05:19 |
 |
Peer-Review Started |
|
2024-01-25 05:19 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2024-02-08 08:38 |
 |
Revised |
|
2024-02-27 14:20 |
 |
Second Decision |
|
2024-03-25 03:00 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2024-03-25 07:23 |
 |
Articles in Press |
|
2024-03-25 07:23 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2024-04-18 07:14 |
 |
Publish the Manuscript Online |
|
2024-04-25 08:14 |
ISSN |
2307-8960 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Infectious Diseases |
Manuscript Type |
Case Control Study |
Article Title |
Clinical analysis of colistin sulfate in the treatment of pneumonia caused by carbapenem-resistant Gram-negative bacteria
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Hai-Chang Xu, Yan Cui, Xue-Ying Wang, Hai-Bo Wu, Wei Li, Dan Wang, Na Lin, Lin Lin and Ying-Hui Zhang |
Funding Agency and Grant Number |
|
Corresponding Author |
Yan Cui, MM, Deputy Director, Department of Intensive Care Medicine, The General Hospital of the Northern Theater Command of the People's Liberation Army of China, No. 83 Wenhua Road, Shenhe District, Shenyang 110003, Liaoning Province, China. cyan9010@qq.com |
Key Words |
Colistin sulfate; Extensively drug-resistant; Pneumonia; Intravenous combined with nebulization; Sepsis; Nephrotoxicity; Neurotoxicity |
Core Tip |
Multidrug-resistant Gram-negative bacteria, exacerbated by excessive use of antimicrobials and immunosuppressants, are a major health threat. Colistin sulfate provides comprehensive, highly sensitive coverage against these bacteria. For pulmonary infections, its use via intravenous and nebulization methods improves cure rates and reduces adverse reactions, including renal and neurotoxicity. It also significantly ameliorates clinical symptoms in sepsis patients, proving to be safe and reliable. |
Publish Date |
2024-04-25 08:14 |
Citation |
Xu HC, Cui Y, Wang XY, Wu HB, Li W, Wang D, Lin N, Lin L, Zhang Y. Clinical analysis of colistin sulfate in the treatment of pneumonia caused by carbapenem-resistant Gram-negative bacteria. World J Clin Cases 2024; 12(13): 2173-2181 |
URL |
https://www.wjgnet.com/2307-8960/full/v12/i13/2173.htm |
DOI |
https://dx.doi.org/10.12998/wjcc.v12.i13.2173 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345